Biotechnology Acquisitions in Delaware

Showing 1 transactions.

  • Lomond Therapeutics Completes Reverse Merger with Venetian-1 and Raises $44M
    November 4, 2024
    Buyer
    Venetian-1 Acquisition Corp., Montrose Capital, OrbiMed, Torrey Pines Investment, Deerfield Management Company, American Financial Group, Heights Capital
    Target
    Lomond Therapeutics, Inc.
    Industry
    Biotechnology
    Location
    Delaware, United States
    Type
    Buyout

    Lomond Therapeutics completed a reverse merger with Venetian-1 Acquisition Corp., which changed its name to Lomond Therapeutics Holdings, Inc., and closed a $44 million private placement led by existing and new investors. The financing included participation from OrbiMed, Torrey Pines Investment, Deerfield Management, American Financial Group and Heights Capital and will fund advancement of Lomond’s clinical-stage oncology programs (lomonitinib, lonitoclax and a menin inhibitor).

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.

Start Free Trial →